Hyphens Pharma International Ltd (sgx:1J5) Share Price

Company Profile

Business description
Hyphens Pharma International Ltd is a pharmaceutical company. Its segments include the Pharmaceutical and Medical Aesthetics segment; Proprietary Brands segment; and Digital Platform and E-Pharmacy segment. The Pharmaceutical and Medical Aesthetics segment engages in the business of marketing and selling a range of pharmaceutical and medical aesthetics products with exclusivity in the relevant ASEAN countries. The Proprietary Brands segment develops, markets, and sells dermatological, pharmaceuticals and health supplement products. The Digital Platform and E-Pharmacy segment is a digital platform servicing procurement needs of healthcare professionals, healthcare institutions, and retail pharmacies, mainly in Singapore.
Contact
16 Tai Seng Street
Level 4
Singapore534138
SGP
T: +65 63388551
https://www.hyphensgroup.com
Sector
Healthcare
Stock type
Defensive
Industry
Medical Distribution
Fiscal Year End
31 December 2026
Employees
474

Recommended

SpaceX has risen 50% from its IPO price to become the second-most-expensive stock under Morningstar’s coverage.

Tom Lauricella | 19 June 2026

Even as competition looks likely to build, the company remains a leading wide-moat business securely at the center of the AI ecosystem.

Brian Colello, CPA | 19 June 2026

Most Australians will end up owning SpaceX — whether they like it or not.

Tyger Fitzpatrick | 19 June 2026

Index	Last price	Change	% Change
All Ordinaries	9,045.50	27.70	-0.31%
CAC 40	8,467.98	37.19	0.44%
DAX 40	25,026.80	92.13	0.37%
Dow JONES (US)	51,564.70	72.15	0.14%
FTSE 100	10,399.70	108.91	-1.04%
HKSE	23,924.81	387.35	-1.59%
NASDAQ	26,517.93	496.28	1.91%
Nikkei 225	71,608.72	555.23	0.78%
NZX 50 Index	13,416.34	53.03	0.40%
S&P 500	7,500.58	80.48	1.08%
S&P/ASX 200	8,827.00	29.60	-0.33%
SSE Composite Index	4,090.48	17.59	-0.43%